Annual report pursuant to Section 13 and 15(d)

Income Taxes (Tables)

v3.24.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets
               
    As of
December 31,
 
    2023     2022  
Deferred tax assets:                
Net operating loss carryforwards   $ 53,225     $ 57,895  
Research credit carryforwards     9,841       10,521  
Other, net     1,980       1,968  
Total deferred tax assets     65,046       70,384  
Deferred tax liabilities:                
Other, net     (19 )     (46 )
Total deferred tax liabilities     (19 )     (46 )
Valuation allowance     (65,027 )     (70,338 )
Net deferred tax assets   $ -     $ -  
Schedule of effective tax rate
               
    For the
Years Ended
December 31,
 
    2023     2022  
Computed at 21%   $ (1,084 )   $ (2,144 )
State taxes     11       (488 )
Change in valuation allowance     (5,310 )     (7,545 )
Other     2       -  
Stock based compensation     218       627  
Research and development credits     (233 )     3,489  
Tax attributes expirations     6,314       6,216  
Impact of IRC 162m     83       (159 )
Total   $ 1     $ (4 )